George Arcos, DO
Pain Medicine · Conway, ARNPI 1255432878
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,000 of the $30,460 with a category attached, or 62.4%. Stimwave Technologies Incorporated accounts for 76.7% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $13,536 and has fallen 90.3% since, to $1,307 in 2025. Among pain medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $179.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stimwave Technologies Incorporated$23K
- Boston Scientific$2K
- Spinal Simplicity, LLC$2K
- Relievant Medsystems, Inc.$1K
- VGI Medical, LLC$629
- Painteq LLC$145
- plus $1K from 24 others
What the payments were for
- Consulting fees$19,00062%
- Travel & lodging$4,76516%
- Food & beverage$6,69522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stimwave Technologies Incorporated | 35 | $23,365 |
| Boston Scientific | 66 | $2,185 |
| Spinal Simplicity, LLC | 9 | $1,710 |
| Relievant Medsystems, Inc. | 8 | $1,281 |
| VGI Medical, LLC | 2 | $629 |
| Painteq LLC | 3 | $145 |
| Collegium Pharmaceutical, Inc. | 6 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $128 |
| Spinefrontier, Inc. | 1 | $121 |
| Alphatec Spine, Inc | 1 | $112 |
| SPR Therapeutics, Inc | 4 | $104 |
| Nevro Corp. | 3 | $67 |
| Forte Bio-pharma LLC | 3 | $55 |
| Medtronic | 3 | $52 |
| Abbott | 2 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| Vertos Medical, Inc. | 2 | $37 |
| Indivior Inc. | 1 | $30 |
| GRT US Holding, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Protega Pharmaceutials Inc | 1 | $22 |
| AbbVie | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| Medline Industries LP | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $14 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCS FreedonSpinal Cord Stimulator$10,952
- StimQ Peripheral Nerve StimulatorSystem$8,000
- CFNS StimQ Peripheral Nerve StimulatorSystem$2,952
- HA MINUTEMAN G3-R$1,515
- Intracept$1,321
- SiJoin$629
- Superion Indirect Decompression System$425
- WaveWriter Alpha Prime 16$145
- NA$143
- GENERAL PAIN MANAGEMENT$133
- InSpan$121
- SIJFuse$121
- FacetFuse$121
- NanoFuse$121
- PAINTEQ$116
How this compares
$30,460 in reported general payments places this provider in the 95th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 53 | $128,377 |
| Xtampza ErOxycodone Myristate | 163 | $46,450 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 723 | $26,463 |
| MovantikNaloxegol Oxalate | 52 | $23,979 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 789 | $21,054 |
| OxycontinOxycodone Hcl | 83 | $20,134 |
| Oxycodone Hcl | 1,072 | $18,232 |
| Buprenorphine | 24 | $9,508 |
| Morphine Sulfate ErMorphine Sulfate | 607 | $8,824 |
| Nucynta ErTapentadol Hcl | 12 | $6,556 |
| Gabapentin | 498 | $6,386 |
| Pregabalin | 383 | $6,054 |
| Lidocaine | 58 | $5,776 |
| Methocarbamol | 88 | $5,283 |
| Morphine Sulfate | 131 | $2,934 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $128 | $128,37753 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er | $134 | $53,005175 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 53 pain medicine providers in Arkansas.
Other pain medicine in Conway
- Daniel JudkinsConway$17K
- Sheffield KentConway$16K
- Thomas WardConway$1K
- Richard MooreConway$45
- Stephen PaulusLittle Rock$75K
- Mark MiedemaFayetteville$35K
- George DeimelFayetteville$26K
- Julio OlayaLittle Rock$22K
- Maria Lyuksyutova-PriceMountain Home$19K
- Christopher MocekLittle Rock$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.